Publications by authors named "Jun Kuwazuru"

Claim this Profile
E
Efficacy of Nrf2 activation in a proteinuric Alport syndrome mouse model.
Shota Kaseda, Jun Horizono, Yuya Sannomiya, Jun Kuwazuru, Mary Ann Suico

Life Sci Alliance· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimerization profile of type IV collagen COL4A5 exon deletion in X-linked Alport syndrome.
Yuimi Koyama, Mary Ann Suico, Aimi Owaki, Ryoichi Sato, Jun Kuwazuru

Clin Exp Nephrol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion.
Jun Kuwazuru, Mary Ann Suico, Kohei Omachi, Haruka Kojima, Misato Kamura

Kidney360· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model.
Shota Kaseda, Yuya Sannomiya, Jun Horizono, Jun Kuwazuru, Mary Ann Suico

Kidney360· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.
Yuya Sannomiya, Shota Kaseda, Misato Kamura, Hiroshi Yamamoto, Hiroyuki Yamada, Jun Kuwazuru

Ren Fail· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin ameliorates the severity of experimental Alport syndrome.
Kohei Omachi, Shota Kaseda, Tsubasa Yokota, Misato Kamura, Keisuke Teramoto, Jun Kuwazuru

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimerization and Genotype-Phenotype Correlation of Mutants in Alport Syndrome.
Misato Kamura, Tomohiko Yamamura, Kohei Omachi, Mary Ann Suico, Kandai Nozu, Jun Kuwazuru

Kidney Int Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Split-Luciferase-Based Trimer Formation Assay as a High-throughput Screening Platform for Therapeutics in Alport Syndrome.
Kohei Omachi, Misato Kamura, Keisuke Teramoto, Haruka Kojima, Tsubasa Yokota, Jun Kuwazuru

Cell Chem Biol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.
Tsubasa Yokota, Kohei Omachi, Mary Ann Suico, Misato Kamura, Haruka Kojima, Jun Kuwazuru

Nephrol Dial Transplant· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.
Tsubasa Yokota, Kohei Omachi, Mary Ann Suico, Haruka Kojima, Misato Kamura, Jun Kuwazuru

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis